Canada markets close in 3 hours 41 minutes

AlzeCure Pharma AB (publ) (AC6.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.1205-0.0150 (-11.07%)
As of 10:18AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 11.29M
Enterprise Value 9.67M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)7.97
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.26

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-62.15%
S&P500 52-Week Change 323.57%
52 Week High 30.5220
52 Week Low 30.1205
50-Day Moving Average 30.1833
200-Day Moving Average 30.2654

Share Statistics

Avg Vol (3 month) 3310
Avg Vol (10 day) 3100
Shares Outstanding 570.06M
Implied Shares Outstanding 683.09M
Float 844.75M
% Held by Insiders 130.57%
% Held by Institutions 14.45%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in SEK.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-59.79%
Return on Equity (ttm)-115.25%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -38.13M
Net Income Avi to Common (ttm)-37.43M
Diluted EPS (ttm)-0.0500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.04M
Total Cash Per Share (mrq)0.31
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.57
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-35.1M
Levered Free Cash Flow (ttm)-21.79M